Oxford Biomedica plc (LON:OXB)

Oxford Biomedica Statistics

Total Valuation

LON:OXB has a market cap or net worth of GBP 750.79 million. The enterprise value is 802.02 million.

Market Cap	750.79M
Enterprise Value	802.02M

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

LON:OXB has 120.90 million shares outstanding. The number of shares has increased by 8.18% in one year.

Current Share Class	120.90M
Shares Outstanding	120.90M
Shares Change (YoY)	+8.18%
Shares Change (QoQ)	+11.13%
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	49.66%
Float	60.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.45
PB Ratio	8.22
P/TBV Ratio	11.35
P/FCF Ratio	n/a
P/OCF Ratio	1,480.86
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.62
EV / Sales	4.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-188.53

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 1.62.

Current Ratio	2.20
Quick Ratio	1.92
Debt / Equity	1.62
Debt / EBITDA	n/a
Debt / FCF	-34.82
Interest Coverage	-2.24

Financial Efficiency

Return on equity (ROE) is -40.37% and return on invested capital (ROIC) is -21.81%.

Return on Equity (ROE)	-40.37%
Return on Assets (ROA)	-6.98%
Return on Invested Capital (ROIC)	-21.81%
Return on Capital Employed (ROCE)	-12.88%
Weighted Average Cost of Capital (WACC)	9.83%
Revenue Per Employee	172,713
Profits Per Employee	-30,837
Employee Count	977
Asset Turnover	0.61
Inventory Turnover	6.65

Taxes

Income Tax	-1.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.97% in the last 52 weeks. The beta is 1.10, so LON:OXB's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	+107.97%
50-Day Moving Average	665.30
200-Day Moving Average	609.63
Relative Strength Index (RSI)	54.33
Average Volume (20 Days)	298,625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:OXB had revenue of GBP 168.74 million and -30.13 million in losses. Loss per share was -0.27.

Revenue	168.74M
Gross Profit	65.98M
Operating Income	-31.10M
Pretax Income	-31.94M
Net Income	-30.13M
EBITDA	-18.26M
EBIT	-31.10M
Loss Per Share	-0.27

Balance Sheet

The company has 96.90 million in cash and 148.13 million in debt, with a net cash position of -51.23 million or -0.42 per share.

Cash & Cash Equivalents	96.90M
Total Debt	148.13M
Net Cash	-51.23M
Net Cash Per Share	-0.42
Equity (Book Value)	91.35M
Book Value Per Share	0.76
Working Capital	101.43M

Cash Flow

In the last 12 months, operating cash flow was 507,000 and capital expenditures -4.76 million, giving a free cash flow of -4.25 million.

Operating Cash Flow	507,000
Capital Expenditures	-4.76M
Depreciation & Amortization	12.84M
Net Borrowing	-884,000
Free Cash Flow	-4.25M
FCF Per Share	-0.04

Margins

Gross margin is 39.10%, with operating and profit margins of -18.43% and -17.85%.

Gross Margin	39.10%
Operating Margin	-18.43%
Pretax Margin	-18.93%
Profit Margin	-17.85%
EBITDA Margin	-10.82%
EBIT Margin	-18.43%
FCF Margin	n/a

Dividends & Yields

LON:OXB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.18%
Shareholder Yield	-8.18%
Earnings Yield	-4.01%
FCF Yield	-0.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2018. It was a reverse split with a ratio of 0.02.

Last Split Date	May 30, 2018
Split Type	Reverse
Split Ratio	0.02

Scores

LON:OXB has an Altman Z-Score of 0.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.05
Piotroski F-Score	3